300+ investors in your industry, stage, and region Get
Any industry
Google
Biotech
Proptech
Climate
Artificial Intelligence
Impact
EdTech
Sustainability
Clean Energy
Retail
Finance
Digital Media
Local
Enterprise Software
Travel
Platforms
Recruiting
Social
Wine and Spirits
Mobile Apps
InsurTech
Oil and Gas
Theatre
Non Profit
Social Impact
Celebrity
Cryptocurrency
SaaS
Film
Crowdfunding
Venture Capital
Infrastructure
Restaurants
Sporting Goods
Fashion
LGBT
Photography
Payments
Renewable Energy
Organic Food
Email
Financial Services
Manufacturing
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Community
Hardware
Gaming
Media (Entertainment)
Facebook
Blockchain
Beauty
Real Estate
Life Science
B2B
Publishing
Food and Beverage
Social Network
Web3
Big Data
Video Games
Education
Medical
Wellness
Medical Device
Art
Social Media
Android
Internet
Franchise
Music
Mobile
Legal
Construction
Automotive
Sports
eSports
Hospitality
Cannabis
Mobile Advertising
Biotechnology
FinTech
Consumer
Transportation
Enterprise
Software
Any country
South Korea
Oceania
Asia
Brazil
Africa
Middle East
Europe
LATAM
Saudi Arabia
Singapore
Finland
Gibraltar
Greece
Norway
Israel
Italy
Lebanon
Liberia
Mexico
Tajikistan
Taiwan
Zimbabwe
Puerto Rico
Russian Federation
Sweden
San Marino
Togo
Tunisia
Zambia
Nigeria
Isle of Man
Mongolia
Pakistan
Oman
Romania
Colombia
Cameroon
Australia
India
New Zealand
China
Indonesia
Sri Lanka
Vietnam
Armenia
Austria
Barbados
Albania
Bangladesh
Belgium
Argentina
Bahrain
Costa Rica
Belarus
Belize
Chile
Switzerland
Czech Republic
Estonia
Algeria
Honduras
Iceland
Cambodia
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Slovenia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Seychelles
Japan
Germany
Canada
United Kingdom
Ireland
Cyprus
Qatar
Spain
South Africa
United Arab Emirates
Azerbaijan
Bulgaria
Bolivia
Bermuda
Bahamas
Egypt
France
Georgia
Faroe Islands
Denmark
Dominican Republic
Ecuador
Croatia
Hong Kong
Ghana
Ethiopia
Grenada
Iraq
Hungary
Jordan
Jersey
Liechtenstein
Mali
Myanmar
Latvia
Morocco
Lithuania
Malaysia
Peru
Portugal
Philippines
Poland
Rwanda
Sierra Leone
Thailand
El Salvador
Senegal
Tanzania
Uruguay
Ukraine
United States
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotech Startup Investors in Italy (June 2026)

The most active venture capital funds and angel investors investing in Italy Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Italy Biotech startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
CDP Venture Capital
VC Fund
12 Italy, United States, United Kingdom Seed, Series A Software, Information Technology, Health Care $488k–$17M
Sofinnova Partners
VC Fund
12 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $6M–$102M
Indaco Venture Partners
VC Fund
9 Italy, Switzerland, United States Series A, Series B Biotechnology, Health Care, Life Science $1.5M–$52M
Italian Angels for Growth
VC Fund
9 Italy, United States, United Kingdom Seed, Angel, Series A Software, E-Commerce, Health Care $219k–$11M
Vertis
VC Fund
7 Italy, United States, United Kingdom Seed, Series A Software, Computer, E-Commerce $823k–$10M
LIFTT
VC Fund
6 Italy, United Kingdom, France Seed, Series A Software, Biotechnology, Manufacturing $329k–$21M
Principia SGR
VC Fund
6 Italy, United States, United Kingdom Series A, Seed Health Care, Biotechnology, Software $329k–$7.7M
Innogest Capital
VC Fund
5 Italy, United States, Spain Series A, Series B Health Care, Medical, Medical Device $1.1M–$29M
A11 Venture
VC Fund
4 Italy, United States Seed, Pre-Seed, Series A Biotechnology, Medical Device, E-Commerce $384k–$1.4M
Green Arrow Capital
VC Fund
4 Italy, United Kingdom Seed, Series A Health Care, Biotechnology, Manufacturing $1.5M–$2.2M
Claris Ventures
VC Fund
4 Italy, United Kingdom Seed, Series A, Series B Biotechnology, Health Care, Therapeutics $2.2M–$25M
UniCredit
VC Fund
4 Italy, Germany, Spain Debt Financing, Post-IPO Debt, Seed Manufacturing, Energy, Renewable Energy $384k–$1.1B
Progress Tech Transfer Fund
VC Fund
3 Italy, Ireland, United Kingdom Series A, Seed Water, Biotechnology, Manufacturing $176k–$15M
Atlante Ventures
VC Fund
3 Italy, United States, Israel Seed, Series A Software, Biotechnology, Hardware $150k–$3.5M
Invitalia Ventures
VC Fund
3 Italy, United States, United Kingdom Series A, Seed Software, Medical, Internet $658k–$6.2M
Club degli Investitori
VC Fund
3 Italy, Switzerland, United Kingdom Seed, Series A Health Care, E-Commerce, Information Technology $197k–$19M
INGENIUM Emilia Romagna
VC Fund
3 Italy Seed, Angel Medical, Health Care, Privacy $2.1M–$2.2M
EUREKA! Venture SGR
VC Fund
3 Italy Seed, Pre-Seed Nanotechnology, Manufacturing, Medical Device $384k–$4.1M
Lazio Innova
VC Fund
2 Italy, United Kingdom Seed, Pre-Seed, Grant Software, Health Care, Artificial Intelligence $27k–$1.9M
Panakes Partners
VC Fund
2 Italy, Switzerland, United Kingdom Series B, Series A, Series C Health Care, Medical, Medical Device $3.3M–$110M
Barbara Castellano
Angel
2 Italy Pre-Seed Health Care, Biotechnology, Medical Device
3LB Seed Capital Srl
VC Fund
2 Italy, United States, United Kingdom Seed, Pre-Seed, Series A E-Commerce, Software, Information Technology $71k–$2.5M
ENEA Tech e Biomedical
VC Fund
2 Italy, Finland Series A, Venture - Series Unknown Health Care, Biotechnology, Medical Device $3.3M–$21M
The Techshop
VC Fund
2 Italy, United Kingdom Seed, Pre-Seed, Series A Software, Artificial Intelligence, Financial Services $658k–$120M
Kering Ventures
VC Fund
2 Italy Series A Biotechnology, Interior Design $12M–$12M
Intesa Sanpaolo
VC Fund
2 Italy, United Kingdom, United States Debt Financing, Post-IPO Debt, Convertible Note Energy, Financial Services, Renewable Energy $299k–$2.5B
StartUp Health
VC Fund
2 United States, Canada, United Kingdom Seed, Pre-Seed Health Care, Wellness, Medical $20k–$4M
European Circular Bioeconomy Fund
VC Fund
2 Germany, Italy, France Series B, Series A, Seed Biotechnology, Artificial Intelligence, AgTech $4.4M–$48M
European Investment Bank
VC Fund
2 France, Germany, The Netherlands Debt Financing, Post-IPO Debt Biotechnology, Health Care, Energy $7.7M–$658M
3B Future Health Fund
VC Fund
2 United States, Italy, United Kingdom Series B, Series A Biotechnology, Therapeutics, Medical $2.7M–$43M
Fondazione Cariverona
VC Fund
2 Italy Seed Venture Capital
Italian Angels for Biotech
VC Fund
2 Italy Seed Health Care, Biotechnology, Pharmaceutical $549k–$2M
Stefano Bernardi
Angel
2 Italy, United Kingdom, France Seed, Pre-Seed Software, Biotechnology, Artificial Intelligence $100k–$45M
Banco BPM
VC Fund
2 Italy, United States, Spain Debt Financing, Post-IPO Debt, Pre-Seed Manufacturing, Renewable Energy, Energy $384k–$878M
byFounders
VC Fund
2 Denmark, United States, Sweden Seed, Pre-Seed, Series A Software, Artificial Intelligence, Health Care $800k–$64M
Elena Paola Lanati
Angel
1 Italy Seed Biotechnology, Manufacturing, Nanotechnology
Crédit Agricole Italia
VC Fund
1 Italy Debt Financing, Seed Financial Services, Finance, Water
a|impact
VC Fund
1 Italy Seed Medical, Health Care, Biotechnology
Pi Campus
VC Fund
1 Italy, United States, United Kingdom Seed, Pre-Seed Software, Mobile, Biotechnology
Exor Ventures
VC Fund
1 United States, Italy, United Kingdom Seed, Series A, Pre-Seed Software, Health Care, FinTech
V-Bio Ventures
VC Fund
1 Belgium, France, United Kingdom Series A, Series B, Seed Biotechnology, Health Care, Medical
European Commission
VC Fund
1 Spain, France, Germany Grant, Seed, Pre-Seed Software, Biotechnology, Health Care
Sparta Capital
VC Fund
1 Italy, Germany Series A, Series B Solar, Life Science, Biotechnology
Angels 4 Impact
VC Fund
1 Italy Seed Consulting, Biotechnology, Manufacturing
Oskare Capital
VC Fund
1 Italy, Denmark, United Kingdom Seed, Pre-Seed, Series A Health Care, Biotechnology, Medical
Angels4Women
VC Fund
1 Italy, United States Seed, Angel Retail, Fashion, Lingerie
Evotec
VC Fund
1 United States, Germany, France Series A, Series B, Seed Biotechnology, Health Care, Therapeutics
Riso Gallo
VC Fund
1 Italy Biotechnology, Interior Design
Index Ventures
VC Fund
1 United States, United Kingdom, France Series A, Series B, Seed Software, E-Commerce, Internet
Forbion Capital Partners
VC Fund
1 United States, United Kingdom, The Netherlands Series B, Series A, Series C Biotechnology, Health Care, Medical
Access all 50 investors in Italy Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

CDP Venture Capital
VC Fund · Rome, Lazio, Italy · 12 investments in Italy Biotech startups

CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 228
  • Round size: Seed $488k–$8.3M; Series A $3.3M–$17M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $197M in 2021

Portfolio highlights

  • Radical Storage — Find your closest luggage storage and enjoy your journey until the very end!
  • Mela Works — Manage your work site with Mela, and generate logbooks and reports with one click. Download Mela now!
  • Multiverse Computing — World leaders in quantum computing for the financial industry. The first quantum & quantum-inspired toolbox for finance.
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 12 investments in Italy Biotech startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 298
  • Round size: Series A $6M–$65M; Series B $10M–$102M; Series C $11M–$100M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely still investing — raised $200M in 2023

Portfolio highlights

  • protera — Protera is advancing the science of protein engineering to address some of the most critical problems and opportunities in food, agriculture, the environment and human health. We streamline protein design and development with MADI, our proprietary deep learning algorithm, to predict high value protein products and enzymes with unprecedented speed.Our in-house lab generates small quantities of the new predicted structures to validate their desired performance. Upon lab validation, we collaborate with our clients on next steps to move from pilot to industrial scale production.
  • Bioptimus — Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
  • T-Therapeutics — T-Therapeutics is a expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. .
Show all investments...

Indaco Venture Partners
VC Fund · Milan, Lombardia, Italy · 9 investments in Italy Biotech startups

VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Series A, Series B
  • Geography: Italy, Switzerland, United States

Investor stats

  • Total investments: 42
  • Round size: Series A $1.5M–$31M; Series B $8.8M–$52M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Easy Rain — Leading a new automotive era: our modular ecosystem of virtual sensors and active hardware makes cars and autonomous platforms truly safe in every condition.
  • CamGraPhIC — Our platform supports the ever-increasing data traffic demand with high-performing and low-power consumption electro-optical engines.
  • Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
Show all investments...

Italian Angels for Growth
VC Fund · Milan, Lombardia, Italy · 9 investments in Italy Biotech startups

IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Health Care
  • Stage:Seed, Angel, Series A
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 100
  • Round size: Seed $329k–$4.6M; Angel $219k–$1.2M; Series A $2.7M–$11M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • Cato AI — Cato AI is a Milan-based B2B SaaS startup that uses AI to automate public tender management.
  • Fitprime — Il Partner unico per il Wellbeing Aziendale
  • Alomana
Show all investments...

Vertis
VC Fund · Milan, Lombardia, Italy · 7 investments in Italy Biotech startups

Vertis is a dynamic and independent investment management company authorised by Bank of Italy. It manages five closed-end funds for qualified investors by participating in research projects, spin-offs, startups and PMI and deals with the investments of the innovative Made in Italy.

Show more...

Investment focus

  • Industry: Software, Computer, E-Commerce
  • Stage:Seed, Series A
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 62
  • Round size: Seed $823k–$3.6M; Series A $1.5M–$10M
  • Lead/follow: 58% lead, 42% follow
  • Last fund: Likely still investing — raised $35M in 2021

Portfolio highlights

  • Tuidi — Tuidi is a tech startup that develops predictive models of AI, with a particular focus on the food distribution sector. They combine methodical study of data, personalization of business processes and speed of integration for to return an output that is not only accurate but also free from interpretation difficulties so as to increase profits,reduce stock outages and optimize inventories.
  • Focoos AI — Focoos reshapes computer vision with ultra-efficient models that drive down costs, automate hardware integration, and ensure peak performance on any device, while promoting sustainability.
  • TimeFlow — TimeFlow is a software that acts as a B2B marketplace dedicated to the technical and managerial consulting sector.
Show all investments...

LIFTT
VC Fund · Turin, Piemonte, Italy · 6 investments in Italy Biotech startups

A not-only-profit operating investment company, eager to create a bridge between innovative ideas, territory and capital.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Manufacturing
  • Stage:Seed, Series A
  • Geography: Italy, United Kingdom, France

Investor stats

  • Total investments: 69
  • Round size: Seed $329k–$4.7M; Series A $2.7M–$21M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • CareGlance — CareGlance is the provider of real-time monitoring systems based on SS-OCT technology. Fast, precise and developed for the industry!
  • Maieutical Labs — I Maieutical Labs sono un insieme di piattaforme ispirate al Mastery Learning, immersive e mobile-oriented, dedicate allo studio nella scuola secondaria
  • Wearable Robotics — Wearable Robotics produces and develops wearable robotic systems and exoskeletons for rehabilitation, assistance and human-power augmentation.
Show all investments...

Principia SGR
VC Fund · Milan, Lombardia, Italy · 6 investments in Italy Biotech startups

Principia is an Italian Venture Capital firm with over Eur 80M under management. Currently Principia has two funds investing in digital start ups and expansion capital opportunities and in particular cases, we invest also in seed opportunities.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Series A, Seed
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 50
  • Round size: Seed $329k–$3.3M; Series A $1.5M–$7.7M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $187M in 2014

Portfolio highlights

  • KLISBio — KLISBio is a medtech company currently developing a variety of regenerative medicine implantable products leveraging the power of silk fibroin to promote an endogenous repair of human soft tissues.
  • ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
  • WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
Show all investments...

Innogest Capital
VC Fund · Milan, Lombardia, Italy · 5 investments in Italy Biotech startups

We are investors in companies that make the difference. We partner with hard-working entrepreneurial visionaries

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Series A, Series B
  • Geography: Italy, United States, Spain

Investor stats

  • Total investments: 68
  • Round size: Series A $1.1M–$11M; Series B $2.7M–$29M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: May invest from a new fund soon — raised $99M in 2015

Portfolio highlights

  • Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. ​ Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
  • Prestiamoci — Prestiamoci is the first community of loans between individuals born in Italy, allowing you to make profitable investment and to obtain loans with installments transparent.With Prestiamoci the providers invest and get Claimants, returning to its original role of the bank safe. Loans shall be paid by people to trustworthy people who want toachieve their life projects, grow their professional activity, better manage expenses and major purchases
  • BetaGlue Technologies — BetaGlue Therapeutics develops innovative targeted cancer therapy solutions using its proprietary YntraDose technology for nuclear medicine.
Show all investments...

A11 Venture
VC Fund · Lucca, Toscana, Italy · 4 investments in Italy Biotech startups

A11-Venture investe nel capitale di startup innovative nei settori della robotica, automazione, meccatronica, cleantech, web e IT. Facilita la nascita e lo sviluppo di business innovativi globali per il futuro dell'economia locale. Contribuisce a costruire aziende, lavoro qualificato, brevetti, innovazione capaci di rilanciare e riportareinvestimenti e risorse sul territorio. I soci di A11 Venture credono fermamente nell’innovazione grazie a ciò è possibile crescere per linee esterne diversificando i propri investimenti, grazie ad un portafoglio di imprese, con una forte risk mitigation derivante dalla gestione professionale di tutti processi: scouting, team building, investimenti, management degli investimenti, accelerazione e disinvestimento.

Show more...

Investment focus

  • Industry: Biotechnology, Medical Device, E-Commerce
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Italy, United States

Investor stats

  • Total investments: 13
  • Round size: Seed $384k–$1.4M
  • Lead/follow: 23% lead, 77% follow

Portfolio highlights

  • Reefilla — Reefilla EV charging services: recharge your car anywhere, anytime
  • Endostart — Endostart development and manufacturing of a new generation medical devices for gastrointestinal endoscopy.
  • Neuron Guard — Neuron Guard, recognized as the best European startup in HEALTH category (Startup Europe Awards - SEUA 2017), is developing a life-saving medical device that aims to become the standard of care for Targeted Temperature Management (TTM) therapy. Every 7 seconds around the world a person suffers of Acute Brain Damage because of CardiovascularDiseases (CVD) and Traumatic Brain Injury (TBI). They are the most costly and prevalent killers in the last 15 years (15 million deaths by CVD in 2015), and the leading cause of disability (the global incidence rate of TBI is 200 per 100k people per year). WHO estimated a global expenditure of $ 330 billion in 2015, but it is going to increase sharply: $ 4 trillion in 2025 - including premature death, disability, and health care costs - just for CVD in LMICs. Temperature is a vital body parameter. It regulates all cellular functions so its management is essential for the good outcome of patients in several medical conditions such as cardiac arrest, stroke, traumatic brain injury, neuro and cardiac surgery, epilepsy, migraine and oncology. Regulating body temperature at a desired level makes all other treatments more effective. The most modern medical approach is the target temperature management, where physicians try to maintain the most favourable temperature for the patient for up to 24-36 hours, preventing excessive warming (fever) or cooling.Our device is a targeted temperature management system composed by a THERAPEUTIC COLLAR POWERED BY A SMART CONTROL UNIT (the size of a small briefcase). The collar transforms the neck into a natural heat exchanger exploiting several physiological and anatomical characteristics of the human body. It is quicker to act on brain tissue but can also function as total body temperature adjusting device if required. A disposable protective shield makes cleaning the collar after each use simple while featuring an optimal safety profile both in term of pathogens and allergens. The control unit collects all the data of the treatment and transmits them to the Emergency Response System. Our mission is to improve the safety of patients on the roadside, at home or in the workplace, and to reduce the costs of chronic care. In fact, Neuron Guard aims to be the only device that can be used in every circumstance, inside and outside the hospital, and allow the user to fully manage the temperature of the patient warming and cooling as necessary. Our vision is to have a Neuron Guard kit in every public place just like the Automatic External Defibrillator (AED) to empower bystanders to immediately react in case of emergency. Under this perspective our device becomes a connected-intelligent platform that takes care of the patient, connects the scene with the Emergency Response System transmitting vital data to improve the readiness and effectiveness of professional intervention.The device is patented in Italy, USA and China. We have made several prototypes in collaboration with Italian and English companies, such as Tecno Elettra Impianti and TWI, tested it in laboratory and published the experimental results on the NeuroCritical Care Journal. We have also conducted a GAP Analysis with another English consulting firm (CDP) and we are testing the human prototype internally. We are seeking to raise 2.5M€ to complete the pre-industrialization, with design and construction of the human device for the pilot trial, finalized the regulatory clearance and launch it into the market in 2019.
Show all investments...

Green Arrow Capital
VC Fund · Milan, Lombardia, Italy · 4 investments in Italy Biotech startups

Green Arrow Capital is an independent financial group specializing in alternative investments across Europe. They represent a one-of-a-kind platform, capable of connecting the financial system with the real economy through the management of private equity, private debt, infrastructure, and special credit situation funds as well as thematic fundssuch as microfinance and funds of funds that are currently under management. Their team has a successful track record in asset management, investment banking, industry sectors, technology startups, management consulting, renewable energy, and has government and regulatory experience. Their group is mainly composed of investment, asset management, and financial advisory companies. Their aim is to create a solid financial platform to launch and manage investment funds dedicated to alternatives and to the real economy.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Seed, Series A
  • Geography: Italy, United Kingdom

Investor stats

  • Total investments: 9
  • Round size: Series A $1.5M–$2.2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Directa Plus — Directa Plus is a nanotechnology company, manufactures nanoparticles.
  • Maticmind S.p.A — Maticmind S.p.A is a company that provides ICT and system integration solutions to telecommunications operators.
  • Glomeria Therapeutics — Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Claris Ventures
VC Fund · Torino, Piemonte, Italy · 4 investments in Italy Biotech startups

Claris Ventures is a venture capital firm supporting the best scientists in building successful life sciences companies that will impact people's lives

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Seed, Series A, Series B
  • Geography: Italy, United Kingdom

Investor stats

  • Total investments: 11
  • Round size: Seed $2.2M–$11M; Series A $6.1M–$25M; Series B $7.9M–$20M
  • Lead/follow: 55% lead, 45% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • NeoPhore — NeoPhore targets the dynamics of cancer neoantigen evolution and makes effective medicines that will become a key part of the next-generation of cancer immunotherapies.
  • ALKemist Bio — ALKemist Bio is a biotech startup developing next-generation T cell therapies that target ALK-positive cancers. By reprogramming the immune system, the company aims to overcome resistance and deliver more effective, lasting treatments for solid tumors.
  • Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
Show all investments...

UniCredit
VC Fund · Milan, Lombardia, Italy · 4 investments in Italy Biotech startups

UniCredit is a pan-European commercial bank offering unique banking services in Italy, Germany, Central and Eastern Europe.

Show more...

Investment focus

  • Industry: Manufacturing, Energy, Renewable Energy
  • Stage:Debt Financing, Post-IPO Debt, Seed
  • Geography: Italy, Germany, Spain

Investor stats

  • Total investments: 100
  • Round size: Seed $384k–$15M; Post-IPO Debt $40M–$1.1B; Debt Financing $417k–$614M
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • FITT — FITT specializes in thermoplastic fluid transfer and management solutions.
  • EuroGroup Laminations — We develop and produce stators and rotors solutions for the energy transition, guaranteeing maximum efficiency and sustainability on a global scale.
  • E4 Computer Engineering — E4 Computer Engineering stands out for its tireless pursuit of the most cutting edge proposals in the IT sector.
Show all investments...

Progress Tech Transfer Fund
VC Fund · Luxembourg, Luxembourg, Luxembourg · 3 investments in Italy Biotech startups

Investment fund specialized in sustainable technologies from universities and public research organizations, start-ups, spin-offs, and entrepreneurs.

Show more...

Investment focus

  • Industry: Water, Biotechnology, Manufacturing
  • Stage:Series A, Seed
  • Geography: Italy, Ireland, United Kingdom

Investor stats

  • Total investments: 13
  • Round size: Seed $176k–$1.6M; Series A $9.9M–$15M
  • Lead/follow: 54% lead, 46% follow

Portfolio highlights

  • WembraneX — WembraneX's goal is to make wastewater treatment facilities more cost-effective by introducing a new class of anti-fouling and anti-biofouling membranes.
  • Naturbeads — Naturbeads creates biodegradable, sustainable and cost competitive cellulose microbeads to replace currently used microplastics.
  • Valuematic — Valuematic realizza soluzioni per il trattamento e gestione dei dati favorendo il miglioramento nei processi organizzativi e informativi di aziende ed enti.
Show all investments...

Atlante Ventures
VC Fund · Milano, Lombardia, Italy · 3 investments in Italy Biotech startups

Atlante Ventures is a leading Italian VC fund, operated by IMI Fondi Chiusi SGR, part of Intesa Sanpaolo Group.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Hardware
  • Stage:Seed, Series A
  • Geography: Italy, United States, Israel

Investor stats

  • Total investments: 46
  • Round size: Seed $150k–$3.5M; Series A $1.5M–$3.3M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: May invest from a new fund soon — last raise in 2007

Portfolio highlights

  • ADmantX — A NEW ERA OF AUDIENCE TARGETINGADmantX is a contextual analysis and data provider that brings audience targeting to a new level. Awarded patent for semantic advertising technology, the company offers a cookie-less solution that allows publishers, ad networks and exchanges, brand managers and agencies to develop more effective online adcampaigns leveraging semantic understanding, natural language processing and sentiment analysis. Founded in Italy as a spin-off of the leading semantic company Expert System, ADmantX is active in Europe and US. Worldwide customers include NBCUniversal, Integral Ad Science, Networked Insights, Banzai, Cadreon, Amnet, Sojern, Media IQ and ADmantX solutions are integrated in key DSP players such as Turn, Adform and AppNexus.
  • YOGITECH — Notizie e approfondimenti di Tecnologia
  • Expert.ai — Expert.ai is the premier artificial intelligence platform for language understanding.
Show all investments...

Invitalia Ventures
VC Fund · Rome, Lazio, Italy · 3 investments in Italy Biotech startups

Invitalia Ventures SGR manages the “Italia Venture Fund I”, a 87€/Ml sized co-investment fund that invests in early stage operations in Italy. They co-invest up to a maximum of 70% in round A (€ 0.5ML - € 1.5ML) in high growth sectors. Invitalia Ventures, with its network of co-investors not only provides risk capital, but also know-how and anetwork for business development. Main LPs includes the Ministery of Economic Development, the European Investment Bank, Cisco Group, the Sardinian Banking Foundation and Metec Group.They are looking for visionary entrepreneurs who share their passion for innovation. Growth is their mission!!For more information please contact us at info@invitaliaventures.it or visit our website: www.invitaliaventures.it

Show more...

Investment focus

  • Industry: Software, Medical, Internet
  • Stage:Series A, Seed
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 30
  • Round size: Seed $658k–$1.6M; Series A $900k–$6.2M
  • Lead/follow: 13% lead, 87% follow
  • Last fund: May invest from a new fund soon — raised $89M in 2017

Portfolio highlights

  • Ecomate — The ESG Rating platform for every company
  • BigProfiles — A deep understanding of customers let a company tailor marketing campaigns and CRM strategies, but companies have only basic data about customers (e.g. gender or age). External data sources like Social Networks, Public Registries and Socio-Demographic data contain rich information about billions of people, like job titles, levels of education,interests and habits.BigProfiles is a Customer Intelligence SAAS that leverages external information about persons to enrich customer profiling: it can profile a company's customers with previously unknown information about them. Thanks to its Identity Resolution algorithm (the result of a PHD), it identifies a person’s information scattered among external sources.Through this technology, BigProfiles provides customer base analytics and behavior predictions: using Artificial Intelligence on enriched profiles allows to predict churn, fraud and willingness to buy.
  • Codemotion — Codemotion is the ecosystem devoted to innovation, focused on developers and coding, open to all programming languages and technologies. Pioneering spirits, it scout the future to deliver a first class experience to our people. Codemotion is one of the biggest tech-conferences in Europe, with an international network of 30.000 developers and 350speakers coming from all over the world and from the most important IT realities.Codemotion draw in its main conferences, thousands of attendees eager to discuss about hottest topics: it tailor for them disruptive proposals ranging from mobile to UX, develops, cloud, big data, gamedev, security, methods, languages, web, Internet of things. Codemotion is also a startup, providing a bunch of services and activities, for personal and business customers.
Show all investments...

Club degli Investitori
VC Fund · Torino, Piemonte, Italy · 3 investments in Italy Biotech startups

Club degli Investitori (Investors Club) is a network of investors and business angels that invest on early-stage SMEs and startups. The community of 300+ Members (entrepreneurs, CEOs, executive managers) actively scouts for investing opportunities on SMEs & startups and invests with a minimum ticket of €200k. The Club supports business byinvesting capital and by leveraging the Members' network and experience.Club degli Investitori is supported by Unicredit and KPMG Italy.

Show more...

Investment focus

  • Industry: Health Care, E-Commerce, Information Technology
  • Stage:Seed, Series A
  • Geography: Italy, Switzerland, United Kingdom

Investor stats

  • Total investments: 94
  • Round size: Seed $197k–$7.6M; Series A $889k–$19M
  • Lead/follow: 23% lead, 77% follow

Portfolio highlights

  • Largix — Largix is the first company to develop and commercially produce 3D Robotic Printers for real production processes. We have invented the "Cold 3D Printing®" technology that makes 3DP possible for real industrial production. Largix uses the most common thermoplastic polymers: Polypropylene and Polyethylene, polymers that nobody else iscapable of printing.
  • Spacest.com By Roomless — Rent directly online with Roomless, the safe and simple platform for those looking for a house for rent.
  • Approxima — Approxima medical is developing a novel treatment for patients with tricuspid valve regurgitation
Show all investments...

INGENIUM Emilia Romagna
VC Fund · 3 investments in Italy Biotech startups

INGENIUM Emilia Romagna was started with EUR 5.30 million by the Emilia Romagna region and EUR 1.7 million from fund managers. Managed by META Investment, the nine-year fund operated through the temporary acquisition of minority stakes in high-opportunity technological companies. It is now fully invested.

Show more...

Investment focus

  • Industry: Medical, Health Care, Privacy
  • Stage:Seed, Angel
  • Geography: Italy

Investor stats

  • Total investments: 5
  • Round size: Seed $2.1M–$2.2M
  • Lead/follow: 60% lead, 40% follow

Portfolio highlights

  • CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
  • GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
  • Angiodroid — Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy.
Show all investments...

EUREKA! Venture SGR
VC Fund · Milano, Lombardia, Italy · 3 investments in Italy Biotech startups

Eureka! is the first independent Italian venture capital Asset Management company exclusively focused on deep tech investments

Show more...

Investment focus

  • Industry: Nanotechnology, Manufacturing, Medical Device
  • Stage:Seed, Pre-Seed
  • Geography: Italy

Investor stats

  • Total investments: 31
  • Round size: Seed $384k–$4.1M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • FLEEPtech — FLEEP Technologies designs and develops printed electronics solutions for the biomedical and smart packaging sectors. The company, spin-off of Istituto Italiano di Tecnologia, was founded in May 2019.FLEEPtech developed a proprietary process for the fabrication of polymer-based integrated circuits based on Organic Thin-Film Transistors, creatingthe intelligent core for electronics systems that are mechanically flexible, printed like magazines and recyclable. FLEEPtech is the missing link in the printed electronics industry between a great number of flexible and printed products (i.e. sensors, actuators and energy supplies) that find little space in being integrated with standard non-flexible electronics. For such reasons, the company's mission revolves around the realization of a general purpose platform for the manufacturing of fully-printed integrated systems, composed by printed sensors, printed actuators, printed energy supplies and harvesters and, of course, printed integrated circuits.
  • INTA Systems — Nanotech and artificial intelligence for biomolecular analysis
  • Alter Eco Pulp — Alter Eco Pulp is a fiber molding company that processes waste and natural cellulose fibers to manufacture disposable products.
Show all investments...

Lazio Innova
VC Fund · Rome, Lazio, Italy · 2 investments in Italy Biotech startups

Lazio Innova is a venture capital firm with its headquarters in Rome in Italy. The firm provides services in areas such as credit support and guarantees, interventions in risk capital, internationalization services, promotion of business networks and services for the creation and enterprise development.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Grant
  • Geography: Italy, United Kingdom

Investor stats

  • Total investments: 20
  • Round size: Seed $186k–$1.9M; Grant $27k–$33k; Pre-Seed $53k–$549k
  • Lead/follow: 45% lead, 55% follow
  • Last fund: May invest from a new fund soon — raised $27M in 2018

Portfolio highlights

  • Joinrs — Cut the noise. Joinrs uses AI to find the jobs that actually match your skills, experience and preferences. Over 2 million job seekers trust Joinrs.
  • Medicud — Medicud develops a device for treating wounds with negative pressure dressing.
  • Ticketoo — Compra e vendi biglietti in modo etico su Ticketoo. La piattaforma sicura per transazioni fan-to-fan. Trova i migliori eventi e assicurati il biglietto per i tuoi spettacoli preferiti.
Show all investments...

Panakes Partners
VC Fund · Milano, Lombardia, Italy · 2 investments in Italy Biotech startups

Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250million under management.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Series B, Series A, Series C
  • Geography: Italy, Switzerland, United Kingdom

Investor stats

  • Total investments: 40
  • Round size: Series A $3.3M–$31M; Series B $9.9M–$60M; Series C $18M–$110M
  • Lead/follow: 53% lead, 47% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
  • EBAMed — EBAMed SA is a Swiss startup based in Geneva whose mission is to enable safe and effective non-invasive treatments of heart arrhythmias with protontherapy. The company is currently developing a medical device to enable non-invasive heart motion imaging and real-time synchronization of the therapeutic beam. This device consists in both hardware andsoftware components and expands treatment possibilities for existing protontherapy centres, enabling them for the first time to treat heart patients.
  • Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Barbara Castellano
Angel · Milan, Lombardia, Italy · 2 investments in Italy Biotech startups

Laura Iris Ferro

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Pre-Seed
  • Geography: Italy

Investor stats

  • Total investments: 3
  • Lead/follow: no public data

Portfolio highlights

  • Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. ​ Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
  • Bio4Dreams — Il primo incubatore italiano certificato di startup innovative in fase very early stage, a capitale totalmente privato, dedicato alle Scienze della Vita.
  • CorFlow Therapeutics AG — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
Show all investments...

3LB Seed Capital Srl
VC Fund · Torino, Piemonte, Italy · 2 investments in Italy Biotech startups

3LB Seed Capital is not an alternative to start-ups incubators and accelerators, rather acts as a complementary reality that helps to enhance your project in terms of attractiveness for the investor and venture capital market.As investors they are the first willing to know if your project has what it takes to grow successfully. If they areconvinced of your potential, they are ready to bet on you, by joining you and helping you to develop your project.3LB Seed Capital does not provide a percentage of equity in exchange for accompanying activities, but relies exclusively on a premium at the time of its first direct investment in your company.

Show more...

Investment focus

  • Industry: E-Commerce, Software, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 21
  • Round size: Seed $71k–$2.5M
  • Lead/follow: 48% lead, 52% follow

Portfolio highlights

  • YoAgents — Yo Agents nasce dalla unione delle competenze di ogni singolo founder messe a fattor comune per creare un sales hub innovativo.
  • Botsociety — Your conversational design suite. Design and prototype your next chatbot or voice assistant. Create a mockup of your project on Messenger, Slack, Google Assistant, Alexa and more. The next generation design solution for chatbots and voice.
  • Metis Precision Medicine — Metis Precision Medicine is a B-Corp founded with the vision of bringing powerful cancer therapies to patients in need. Metis owns the intellectual property of a suite of anti-Met monoclonal antibodies (mAbs), with different and unique mechanisms of action, and is currently seeking investors, biotech or pharmaceutical companies interested inacquiring the relevant platform technology on a global basis.
Show all investments...

ENEA Tech e Biomedical
VC Fund · Rome, Lazio, Italy · 2 investments in Italy Biotech startups

ENEA Tech e Biomedical is a private foundation. It seeks to encourage the strengthening of research, development, and industrial reconversion of the biomedical sector.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Venture - Series Unknown
  • Geography: Italy, Finland

Investor stats

  • Total investments: 12
  • Round size: Series A $3.3M–$7.7M; Venture - Series Unknown $8.4M–$21M
  • Lead/follow: 92% lead, 8% follow

Portfolio highlights

  • CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
  • Recornea — Recornea is a developer of a corneal medical device to restore the physiological curvature of the cornea with clear and predictable clinical outcomes.
  • Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. ​ Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
Show all investments...

The Techshop
VC Fund · Milan, Lombardia, Italy · 2 investments in Italy Biotech startups

The Techshop is a venture capital and private equity firm that invests in B2B digital startups.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Financial Services
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Italy, United Kingdom

Investor stats

  • Total investments: 20
  • Round size: Seed $658k–$8.1M; Pre-Seed $658k–$38M; Series A $8.2M–$120M
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • hlpy — hlpy operates as a roadside assistance company. Hlpy provides a digital roadside assistance service via a network of 580+ centers, 1,900+ drivers/mechanics, 2,800+ tow trucks.
  • Klaaryo
  • Smartness — Smartpricing is a provider of computer software application and revenue management system solutions to Hotel.
Show all investments...

Kering Ventures
VC Fund · Paris, Ile-de-France, France · 2 investments in Italy Biotech startups

Kering Ventures is the venture investment arm of the Kering Group, acquiring minority holdings in startups.

Show more...

Investment focus

  • Industry: Biotechnology, Interior Design
  • Stage:Series A
  • Geography: Italy

Investor stats

  • Total investments: 2
  • Round size: Series A $12M–$12M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • MOGU — By employing one of its finest technologies, mycelium, Mogu delivers responsible products for interior design. Mycelium design with Mogu.
  • SQIM — SQIM is a biotechnological based agency.
Show all investments...

Intesa Sanpaolo
VC Fund · Torino, Piemonte, Italy · 2 investments in Italy Biotech startups, 7 in the past 12 months

Intesa Sanpaolo is a banking group that specializes in wealth management, protection, advisory, and digital orientation. Their products and services include accounts, cards, loans, mortgages, insurance, digital payments, retirement planning, investments, and consulting. It was founded by the merger of Banca Intesa and Sanpaolo IMI.

Show more...

Investment focus

  • Industry: Energy, Financial Services, Renewable Energy
  • Stage:Debt Financing, Post-IPO Debt, Convertible Note
  • Geography: Italy, United Kingdom, United States

Investor stats

  • Total investments: 122
  • Round size: Post-IPO Debt $112M–$2.5B; Debt Financing $878k–$1.1B; Convertible Note $299k–$2.2M
  • Lead/follow: 34% lead, 66% follow

Portfolio highlights

  • NextGeo
  • Goglio Group — Goglio Group produces full trademark food packaging.
  • EuroGroup Laminations — We develop and produce stators and rotors solutions for the energy transition, guaranteeing maximum efficiency and sustainability on a global scale.
Show all investments...

StartUp Health
VC Fund · New York, New York, United States · 2 investments in Italy Biotech startups

Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots

Show more...

Investment focus

  • Industry: Health Care, Wellness, Medical
  • Stage:Seed, Pre-Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 194
  • Round size: Seed $100k–$4M; Pre-Seed $20k–$800k
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Jiseki Health — Jiseki is built on the belief that families and communities need and deserve a safety net, and to have peace of mind when things go wrong. We provide access and delivery of key advice, help, products and services through highly scalable SMS technology, powered by a combination of professionals and AI, and sold as a portable life benefit package..Text #help to 543210, to discover Jiseki services.
  • Biome Analytics — Biome is an analytic applications that help cardiovascular teams do their best work. It helps forward thinking hospitals profitably transition and thrive in the new world of healthcare. During COVID-19, Biome has focused on assessing hospital capacity.
  • NEXT Life Sciences — NEXT Life Sciences is developing the revolutionary Plan A™ procedure to bring the only scientifically proven technology in the category - Vasalgel® - to market.
Show all investments...

European Circular Bioeconomy Fund
VC Fund · Bonn, Nordrhein-Westfalen, Germany · 2 investments in Italy Biotech startups

The specialist VC for a regenerative economy

Show more...

Investment focus

  • Industry: Biotechnology, Artificial Intelligence, AgTech
  • Stage:Series B, Series A, Seed
  • Geography: Germany, Italy, France

Investor stats

  • Total investments: 19
  • Round size: Series A $4.7M–$30M; Series B $4.4M–$48M
  • Lead/follow: 68% lead, 32% follow
  • Last fund: Likely still investing — raised $351M in 2022

Portfolio highlights

  • AmphiStar — We are developing a proprietary technology platform for the ecological production of biosurfactants, that are clean, safe, sustainable and biodegradable
  • Biosyntia — Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high-throughput screening technology.By developing tailored processes based on biocatalysis, Biosyntia enables production of complex chemical compounds byfermentation. Biocatalysis may substantially reduce both production costs and environmental impact compared to other processes such as chemical synthesis. We partner with manufacturers of fine chemical compounds (flavors, fragrances, APIs, pigments, additives, intermediates, and more) in order to establish more sustainable manufacturing processes for a greener tomorrow.Biosyntia is located at the Novo Nordisk Foundation (NNF) Center for Biosustainability in Hørsholm, 25 kilometers north of Copenhagen.
  • Elicit Plant — We work with farmers around the world to meet the challenges of climate change and the impact of water scarcity on field crops.
Show all investments...

European Investment Bank
VC Fund · Luxembourg, Luxembourg, Luxembourg · 2 investments in Italy Biotech startups

The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Energy
  • Stage:Debt Financing, Post-IPO Debt
  • Geography: France, Germany, The Netherlands

Investor stats

  • Total investments: 294
  • Round size: Post-IPO Debt $7.7M–$658M; Debt Financing $13M–$400M
  • Lead/follow: 78% lead, 22% follow

Portfolio highlights

  • IPT PowerTech — IPT PowerTech coverage, coupled with our extensive expertise in supply chain management, field implementation, and power systems, has made us one of the most capable companies in handling the most complicated and versatile projects in the MEA region and its neighboring countries.
  • Interconnect Malta — Interconnect Malta is a government organization that develops and implements energy infrastructure projects.
  • NVision Imaging Technologies — NVision Imaging Technologies is leveraging advances in quantum physics to enable the first routine, convenient and affordable use of Magnetic Resonance Imaging (MRI) for assessing early patient response to cancer treatment at the metabolic level.
Show all investments...

3B Future Health Fund
VC Fund · Monaco, Bayern, Germany · 2 investments in Italy Biotech startups

Helsinn Investment Fund S.A. is a Luxembourg fund focused on early-stage investments in areas of high unmet patient need.

Show more...

Investment focus

  • Industry: Biotechnology, Therapeutics, Medical
  • Stage:Series B, Series A
  • Geography: United States, Italy, United Kingdom

Investor stats

  • Total investments: 31
  • Round size: Series A $2.7M–$43M; Series B $7.9M–$40M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • NeoPhore — NeoPhore targets the dynamics of cancer neoantigen evolution and makes effective medicines that will become a key part of the next-generation of cancer immunotherapies.
  • Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
  • On Target Laboratories — ON TARGET LABORATORIES discovers and develops fluorescent markers to target and illuminate cancer during surgery so it can be removed more completely.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Fondazione Cariverona
VC Fund · Verona, Veneto, Italy · 2 investments in Italy Biotech startups

Fondazione Cariverona. Da oltre 25 anni per lo sviluppo civile, culturale ed economico di Verona, Vicenza, Belluno, Ancona e Mantova.

Show more...

Investment focus

  • Industry: Venture Capital
  • Stage:Seed
  • Geography: Italy

Investor stats

  • Total investments: 4
  • Lead/follow: 75% lead, 25% follow

Portfolio highlights

  • Noiet — Noiet is a biotechnology firm whose mission is to develop clean, natural, and fermented proteins that serve as multifunctional alternatives.
  • Peelpack — Peelpack is a packaging company that specializes in biodegradable and compostable biopolymer punnets, aiming to replace plastic packaging.
  • Alma Serum — Alma Serum is a cosmetic and biotech company that turns dairy industry into advanced cosmetic and biomedical materials.
Show all investments...

Italian Angels for Biotech
VC Fund · 2 investments in Italy Biotech startups

Angel group focuses on biotech

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Pharmaceutical
  • Stage:Seed
  • Geography: Italy

Investor stats

  • Total investments: 4
  • Round size: Seed $549k–$2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • MgShell — MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures.
  • CaSRevolution — A novel disease-modifying approach against neurodegeneration
  • Metis Precision Medicine — Metis Precision Medicine is a B-Corp founded with the vision of bringing powerful cancer therapies to patients in need. Metis owns the intellectual property of a suite of anti-Met monoclonal antibodies (mAbs), with different and unique mechanisms of action, and is currently seeking investors, biotech or pharmaceutical companies interested inacquiring the relevant platform technology on a global basis.
Show all investments...

Stefano Bernardi
Angel · San Francisco, California, United States · 2 investments in Italy Biotech startups

Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Artificial Intelligence
  • Stage:Seed, Pre-Seed
  • Geography: Italy, United Kingdom, France

Investor stats

  • Total investments: 17
  • Round size: Seed $100k–$45M; Pre-Seed $1.4M–$2.2M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • iubenda — Make your sites & apps legally compliant across multiple languages and legislations (including the GDPR) with our lawyer-crafted, self-updating solutions.
  • Eden Bio — Eden Bio is a biotech using machine learning to guide the genetic engineering of microorganism strain optimisation, improving protein yield.
  • Golden — Golden is a developer of a self-constructing knowledge database used to accelerate discovery and education. The company uses and leverages human effort by using machine intelligence to make the process of gathering and communicating knowledge simpler.It combines a powerful search across several entities with fine-grain alerts to stay on top ofchanges, and semi-automatic research assistance for gaps in knowledge that enable people in organizations to stay current, understand and leverage the latest trends in their industry.
Show all investments...

Banco BPM
VC Fund · Milan, Lombardia, Italy · 2 investments in Italy Biotech startups

Scopri i servizi bancari e finanziari di Banco BPM: conti, mutui, carte, prestiti, assicurazioni, trading e tanto altro. Per privati e imprese.

Show more...

Investment focus

  • Industry: Manufacturing, Renewable Energy, Energy
  • Stage:Debt Financing, Post-IPO Debt, Pre-Seed
  • Geography: Italy, United States, Spain

Investor stats

  • Total investments: 40
  • Round size: Post-IPO Debt $8.8M–$878M; Debt Financing $384k–$614M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • The Stevanato Group — Stevanato Group is a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development,clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients.
  • EuroGroup Laminations — We develop and produce stators and rotors solutions for the energy transition, guaranteeing maximum efficiency and sustainability on a global scale.
  • Aviapartner Handling SpA — Aviapartner Handling is the European provider of airport ground handling services. Aviapartner Handling is the subsidiary of Aviapartner.
Show all investments...

byFounders
VC Fund · Copenhagen, Hovedstaden, Denmark · 2 investments in Italy Biotech startups, 11 in the past 12 months

byFounders is the community-powered early-stage venture fund investing in globally ambitious teams connected to the Nordic and Baltic countries. With its unique Collective of founders and operators, byFounders offers its portfolio operational expertise and a global network. Believing in the power of tech to shape our future, byFounders takes an impact-aware approach to investing and working with the broader startup ecosystem.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Denmark, United States, Sweden

Investor stats

  • Total investments: 98
  • Round size: Seed $1.5M–$7.6M; Pre-Seed $800k–$4.2M; Series A $6.1M–$64M
  • Lead/follow: 49% lead, 51% follow
  • Last fund: Likely still investing — raised $117M in 2021

Portfolio highlights

  • Flare — Flare builds infrastructure for a more internet by connecting real-world data with machine learning in a verifiable way.This combines human intelligence with advanced AI to improve the clarity and reliability of information.Its goal is to create a shared, high-quality knowledge foundation that helps people navigate information with confidence.
  • DataCrunch.io — DataCrunch is a cloud service provider which facilitates utilization and integration of state of the art AI/ML models
  • Spiral Hydrogen — Spiral Hydrogen's mission is to lower the price of green hydrogen below that of fossil hydrogen, so opening up an industry for decarbonization and making hydrogen transportation and heating commercially viable.
Show all investments...

Elena Paola Lanati
Angel · 1 investments in Italy Biotech startups

Elena Paola Lanati

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Nanotechnology
  • Stage:Seed
  • Geography: Italy

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Diamante — Diamante is a company that develops and manufactures autoimmune disease diagnosis devices using nanomaterials. It exploits plants as bioreactors for the sustainable production of nanoparticles based on modified plant viruses that are used in developing new tools. Diamante was founded in 2016 and is headquartered in Verona, Italy.
Show all investments...

Crédit Agricole Italia
VC Fund · Parma, Emilia-Romagna, Italy · 1 investments in Italy Biotech startups

Crédit Agricole Italia is a bank that offers loans and financial services.

Show more...

Investment focus

  • Industry: Financial Services, Finance, Water
  • Stage:Debt Financing, Seed
  • Geography: Italy

Investor stats

  • Total investments: 9
  • Lead/follow: no public data

Portfolio highlights

  • Krill Design — Krill Design is a design studio that creates circular economy projects to convert organic waste into material resources. It is a patented process that intercepts resources from the food supply chain to create zero-impact eco-designed 3D printed products.
  • Italcer Group — Italcer Group is a manufacturer of indoor and outdoor ceramic products.
  • Ital Gas Storage — Ital Gas Storage is a gas storage company that offers storage services.
Show all investments...

a|impact
VC Fund · 1 investments in Italy Biotech startups

a|impact invests in the prevailing form of equity or quasi-equity, focusing our operations mainly on companies.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed
  • Geography: Italy

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • GenomeUp — GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. GenomeUp is involved in international research projects and clinical trials in partnership with universities and research centers.
Show all investments...

Pi Campus
VC Fund · Rome, Lazio, Italy · 1 investments in Italy Biotech startups

Pi Campus is a startup district and a venture fund that invests in talent. We provide startups with money, mentorship and the best work environment for growth.

Show more...

Investment focus

  • Industry: Software, Mobile, Biotechnology
  • Stage:Seed, Pre-Seed
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 51
  • Lead/follow: no public data

Portfolio highlights

  • Loquis — La prima piattaforma per ascoltare e raccontare il mondo tramite podcast geolocalizzati
  • Fondo — Fondo is an all-in-one accounting platform for startups. We'll handle your bookkeeping, tax, and tax credits so you can focus on building your startup.
  • Intron Health — Intron is the future of clinical documentation with real-time clinical speech-to-text for 200+ African accents, easing the transition to digitized care.
Show all investments...

Exor Ventures
VC Fund · New York, New York, United States · 1 investments in Italy Biotech startups, 15 in the past 12 months

Exor Ventures is the venture capital arm of Exor, one of Europe's largest diversified holding companies. Exor Ventures focuses on early and growth-stage investments in technology-driven companies across various sectors, including digital services, fintech, cybersecurity, and mobility. Exor Ventures leverages its strategic insights and globalnetwork to identify promising startups with disruptive potential and supports them through funding, mentorship, and access to its extensive resources. EXOR Seeds offers a truly different type of partnership to the select group of entrepreneurs that it backs:- As a fifth-generation family-led business, we proved that we are builders not traders;- Our permanent capital allows us to take a long-term view and put the interest of the companies We invest in first;- Our global network, across industries and geographies, is a unique advantage to entrepreneurs

Show more...

Investment focus

  • Industry: Software, Health Care, FinTech
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Italy, United Kingdom

Investor stats

  • Total investments: 127
  • Lead/follow: no public data

Portfolio highlights

  • N5 Now — N5 has developed the way out of your complex legacy systems and into the fintech digital world, without having to change your core technology. Contact Us!
  • PhaseV — PhaseV empowers biopharma sponsors and CROs with AI/ML-driven solutions for fast, efficient, and accurate clinical development decisions.
  • Byzantine Finance — Stake assets, secure other services, and earn more. Restake now with Byzantine Finance to become part of DeFi's next generation. Building the most secure and profitable future for staking.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
V-Bio Ventures
VC Fund · Gent, Oost-Vlaanderen, Belgium · 1 investments in Italy Biotech startups

V-Bio Ventures is an independent venture capital firm specialized in building and financing young, innovative life science companies. The fund invests throughout Europe in start-up and early-stage companies with high growth potential focusing on technologies that provide transformational improvements in the biotech, pharmaceutical and agriculturalsectors.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Seed
  • Geography: Belgium, France, United Kingdom

Investor stats

  • Total investments: 28
  • Lead/follow: no public data

Portfolio highlights

  • AstriVax — AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.
  • Precirix — Developing radio-immunotherapeutic drugs for cancer patients.
  • Sibylla Biotech — Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.
Show all investments...

European Commission
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 1 investments in Italy Biotech startups

The official website of the European Commission, providing access to information about its political priorities, policies and services

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Grant, Seed, Pre-Seed
  • Geography: Spain, France, Germany

Investor stats

  • Total investments: 187
  • Lead/follow: no public data

Portfolio highlights

  • Orfium — Find, use, track, and monetize music content across all channels with Orfium's industry-leading music rights management software.
  • CyberRidge — CyberRidge is a deep-tech cybersecurity firm that develops photonic encryption to protect data privacy.
  • Powerful Medical — Powerful Medical is a deep-tech company, tackling the most challenging problems of modern medicine using artificial intelligence and machine learning.
Show all investments...

Sparta Capital
VC Fund · Toronto, Ontario, Canada · 1 investments in Italy Biotech startups

Sparta Capital Ltd. focuses on product development, manufacturing, distribution, sales and service across a range of technologies. The Company's offering includes four different market verticals: transportation, mining, construction and energy (through biomass conversion). These offerings include optimization of energy consumption in thecommercial and manufacturing sectors, construction and energy through biomass conversion, energy conservation in mining, and energy savings in transportation. It is focused on the expansion of a range of divisions, including photoluminescent safety products division, energy audit (EMD) division, biomass division and mining division.

Show more...

Investment focus

  • Industry: Solar, Life Science, Biotechnology
  • Stage:Series A, Series B
  • Geography: Italy, Germany

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Sunvigo — Sunvigo provides you with cheap solar power from your roof and real green power from the grid.
  • GFBiochemicals — GFBiochemicals is the only company to produce levulinic acid derivatives at commercial scale directly from biomass.
Show all investments...

Angels 4 Impact
VC Fund · Milan, Lombardia, Italy · 1 investments in Italy Biotech startups

Angels 4 Impact is a Business Angel investment firm that invests in startups with innovative and technological content and a focus on impact.

Show more...

Investment focus

  • Industry: Consulting, Biotechnology, Manufacturing
  • Stage:Seed
  • Geography: Italy

Investor stats

  • Total investments: 3
  • Lead/follow: no public data

Portfolio highlights

  • Diamante — Diamante is a company that develops and manufactures autoimmune disease diagnosis devices using nanomaterials. It exploits plants as bioreactors for the sustainable production of nanoparticles based on modified plant viruses that are used in developing new tools. Diamante was founded in 2016 and is headquartered in Verona, Italy.
  • Envirly — Envirly is a Polish technology company that offers an innovative platform for managing sustainable development, and the carbon footprint of organizations and products.
  • Vado — Vado is a technology startup that connects third-party delivery platforms and vending machines making order reception, management and delivery to the riders completely automatic.We are neither a delivery provider nor a vending machine manufacturer - we bridge the gap between them.In order to help companies manage the delivery and take-awayoperations of any product (Alcohol, Sushi, Drugs, Ready Foods) more efficiently, we integrate their delivery apps (Glovo, Deliveroo, JustEat, UberEats) with distributors automatic that allow you to sell automatically 24/7.Automating the online ordering process helps our customers save time and money, so they can focus more on their core business and continue doing what they love most: making their customers happy.
Show all investments...

Oskare Capital
VC Fund · Paris, Ile-de-France, France · 1 investments in Italy Biotech startups

Oskare Capital is a venture capital firm.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Italy, Denmark, United Kingdom

Investor stats

  • Total investments: 5
  • Lead/follow: no public data

Portfolio highlights

  • Leva Clinic — Leva Clinic offers health care services for people with chronic pain. Their medical services include back pain, cancer pain, endometriosis, facial pain, fibromyalgia, joint pain, knee pain, multiple sclerosis, sciatica, and so on.
  • Octarine Bio — Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry.
  • Herbolea Biotech — Unique bio-processing technologies NATURAL, SOLVENT-LESS Botanical extraction Learn more
Show all investments...

Angels4Women
VC Fund · Milan, Lombardia, Italy · 1 investments in Italy Biotech startups

Angels4Women is a company that invests in business startups lead by females.

Show more...

Investment focus

  • Industry: Retail, Fashion, Lingerie
  • Stage:Seed, Angel
  • Geography: Italy, United States

Investor stats

  • Total investments: 3
  • Lead/follow: no public data

Portfolio highlights

  • Diamante — Diamante is a company that develops and manufactures autoimmune disease diagnosis devices using nanomaterials. It exploits plants as bioreactors for the sustainable production of nanoparticles based on modified plant viruses that are used in developing new tools. Diamante was founded in 2016 and is headquartered in Verona, Italy.
  • FUTURELY — FUTURELY is a platform which will help to choose university.
  • Chite Milano — Lingerie the Italian way. Discover 100% Made in Italy lingerie. Make your own: customise your lingerie and nightwear.
Show all investments...

Evotec
VC Fund · Hamburg, Hamburg, Germany · 1 investments in Italy Biotech startups

Evotec is a global biotechnology company committed to advancing drug discovery & development together with our partners for medicines that matter.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Germany, France

Investor stats

  • Total investments: 21
  • Lead/follow: no public data

Portfolio highlights

  • Aptadir Therapeutics — Reprogramming DNA methylation in disease conditions by RNA therapeutics APTADIR Contact us NEWS Press Release Reprogramming DNA methylation by RNA therapeutics A novel therapeutic approach for untreatable cancers and rare diseases Aberrant methylation by DNA methyltransferase 1 (DNMT1) of certain genes may cause abnormal cell development and lead to disease. Current therapies targeted to inhibit
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
  • Aeovian Pharmaceuticals — Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.
Show all investments...

Riso Gallo
VC Fund · Robbio, Lombardia, Italy · 1 investments in Italy Biotech startups

Riso Gallo is a rice producer specializing in processing, and distributing of risotto rice to consumers around the world.

Show more...

Investment focus

  • Industry: Biotechnology, Interior Design
  • Geography: Italy

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • MOGU — By employing one of its finest technologies, mycelium, Mogu delivers responsible products for interior design. Mycelium design with Mogu.
Show all investments...

Index Ventures
VC Fund · San Francisco, California, United States · 1 investments in Italy Biotech startups, 59 in the past 12 months

Index Ventures is an international venture capital firm with dual headquarters in San Francisco and London, investing in technology-enabled companies with a focus on e-commerce, fintech, mobility, gaming, infrastructure/AI, and security.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Internet
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 972
  • Lead/follow: no public data

Portfolio highlights

  • Duna — Meet the modern platform that accelerates business onboarding, automates manual work and grows revenue.
  • Hedra — Video creation for everyone.
  • Persona — Online ID verification service to help any business, from any industry, collect, verify, and manage user identities throughout a customer lifecycle.
Show all investments...

Forbion Capital Partners
VC Fund · Naarden, Noord-Holland, The Netherlands · 1 investments in Italy Biotech startups, 6 in the past 12 months

Impacting the future of medicine.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, United Kingdom, The Netherlands

Investor stats

  • Total investments: 152
  • Lead/follow: no public data

Portfolio highlights

  • Azafaros — Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
  • Eeden — Eeden engages in the manufacture and supply of textiles.
  • Granite Bio — Targeting fundamentals of Inflammation, Autoimmunity and Fibrosis. Granite Bio develops first-in-class therapeutic antibodies depleting pathogenic cells with the potential to transform inflammatory and fibrotic diseases.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech Investors in Italy investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 investors investing in Italy Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists